NCT05303519 · Interventional trial
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Overall registry status Recruiting
Phase 3
Conditions Astrocytoma, Grade IV, Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4, Glioma, IDH1-mutant Glioma, Oligodendroglioma, Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted
Delaware Valley sites
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory